Revolutions Medical to Exhibit in the 141st American Correctional Association Conference


CHARLESTON, S.C., July 18, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) will exhibit at the 141st American Correctional Association Conference (the "ACA Conference"), August 5-10th in Kissimmee Florida. The 141st Congress of Correction Conference is one of the largest mediums for engaging high-level decision makers at the federal, state, and local levels of corrections. The annual ACA Conference showcases the latest innovations in corrections technology, healthcare, probation and parole, transportation and training to these thousands of decision makers in the correctional industry.

Exposure to blood and other body fluids occurs across a wide variety of occupations, however correctional personnel are at a greater exposure risk each and every day. Corrections personnel come to work with additional concerns relating to life-altering events such as accidental needle stick injuries. More than 22,000 inmates in federal and state prisons have HIV (almost four times the general population). Hepatitis B virus (HBV) and hepatitis C virus (HCV) is much higher among inmates than in the community. Also, the World Health Organization (WHO) estimates the prevalence of Tuberculosis (TB) is up to 100 times higher in prison than in the community.

"The RevVac auto retractable vacuum safety syringe can provide a valuable solution to what appears to be frightening statistics related to not only providing safer injections but also a safer overall medical environment in our correctional institutions," stated Ron Wheet, Chairman and Chief Executive Officer. "We are excited to be participating at the ACA conference and to demonstrate our innovative safety syringe."

For more information on this topic go to www.isips.org

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).

For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com

To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.



            

Contact Data